Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients

Rheumatology

Volumn 46, Issue 12, 2007, Pages 1769-1772

  Anitua, E ^a   Sanchez M ^b   Nurden, A T ^c   Zalduendo, M M ^a   De la Fuente, M ^a   Azofra, J ^b   Andía, Isabel ^a,d  

^a Biotechnology Institute BTI   (Spain)

^b Unidad de Cirugia Artroscopica   (Spain)

^c IFR4/FR21   (France)

^d Biotechnology Institute   (Spain)

Author keywords

Growth factors; IL ; Osteoarthritis; Platelet rich plasma; Synovial cells

Indexed keywords

COLLAGENASE 3; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; SYNOVIUM; TREATMENT OUTCOME;

AGED; CELLS, CULTURED; FEMALE; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; HYALURONIC ACID; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROBABILITY; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SYNOVIAL MEMBRANE; THYMIDINE PHOSPHORYLASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36448939768     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem234     Document Type: Article

References (33)

1. Haywood L, McWilliams DF, Pearson CI et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003;48:2173-7.
2. Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: Relevance to osteoarthritis. Adv Drug Dellv Rev 2006;58:212-25.
3. Lauder SN, Carty SM, Carpenter CE et al. Interleukin-1β induced activation of nuclear factor-κB can be inhibited by novel pharmacological agents in osteoarthritis. Rheumatology 2007;46:752-8.
4. Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet-derived growth factor on in vivo cartilage healing and repair. Ostearthr Cartilage 2005;14:403-12.
5. Anitua E, Carda C, Andía I. A novel drilling procedure and subsequent bone autograft preparation: A technical note. Int J Oral Maxillofac Implants 2007;22:138-45.
6. Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andia I. New insights into and novel applications for platelet-rich therapies. Trends Biotechnol 2006;24:227-34.
7. Sanchez M, Anitua E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007;35:245-51.
8. Sánchez M, Azofra J, Anitua E et al. Plasma rich in growth factors to treat an articular cartilage avulsion: A case report. Med Sci Sports Exerc 2003;35:1648-52.
9. Mix KS, Spom MB, Brinckerhoff CE, Eyre D, Schurman DJ. Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritis. Clin Orthop Relat Res 2004;427:129-37.
10. Anitua E, Andia I, Ardanza B, Nurden P, Nurcion AT. Autologous platelets as a source for healing and tissue regeneration. Thromb Haemost 2004;91:4-15.
11. Anitua E, Andia I, Sanchez M et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23:281-6.
12. Anitua E, Sanchez M, Nurden AT et al. Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A 2006;77:285-93.
13. Pietrzak WS, Eppley BL. Platelet rich plasma: Biology and new technology. J Craniofac Surg 2005;16:1043-54.
14. Blaney Davidson EN, van der Kraan PM, van der Berg WB. TGF-beta and osteoarthritis. Osteoarthr Cartilage 2007;15:597-604.
15. Oguchi T, Ishiguro N. Differential stimulation of three forms of hyaluronan synthase by TGF-beta, IL-1β and TNF-alpha. Connect Tissue Res 2004;45:197-205.
16. Jacobson A, Brinck J, Briskin MJ, Spicer AP, Heldin P. Expression of human hyaluronan synthases in response to external stimuli. Biochem J 2000;348:29-35.
17. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004;427:27-36.
18. Fuchs S, Skwara A, Bloch M, Dankbar B. Differential induction and regulation of matrix metalloproteinases in osteoarthrc tissue and fluid synovial fibroblasts. Osteoarthritis Cartilage 2004;12:409-18.
19. Tortorella MD, Amer EC, Hills R et al. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem 2004;279:17554-61.
20. Enomoto H, Inoki I, Komiya K et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 2003;162:171-81.
21. Hashimoto S, Creighton-Achermann L, Takahashi K et al. Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis cartilage 2002; 10: 180-7.
22. Tanaka E, Aoyama J, Miyauchi M et al. Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis. Histochem Cell Biol 2005;123:275-81.
23. Inoue K, Masuko-Hongo K, Okamoto M, Nishioki K. Induction of vascular endothelial growth factor and matrix metalloproteinase-3 (stromelysin) by interleukin-1 in human articular chondrocytes and synoviocytes. Rheumatol Int 2005;26:93-8.
24. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology 2005;44:7-16.
25. Xin X, Yang S, Ingle G et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 2001;158:1111-20.
26. Beilmann M, Birk G, Lenter MC. Human primary co-culture angiogenesis assay reveals additive stimulation and different angiogenic properties of VEGF and HGF. Cytokine 2004;26:178-85.
27. Gerritsen ME, Tomlinson JE, Zlot C, Ziman M, Hwang S. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial calls. Br J Pharmacol 2003;140:595-610.
28. Min JK, Lee YM, Kim JH et al. Hepatocyte growth factor suppresses VEGF-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res 2005;96:300-7.
29. Anitua E, Sanchez M, Nurden AT et al. Reciprocal actions of platelet-secreted TGF-beta 1 on the production of VEGF and HGF by human tendon cells. Pleat Reconstr Surg 2007;119:950-9.
30. Takami Y, Kanasaki K, Tsubouchi H, Ishii T, Yamamoto I, Gohda E. Inhibition of hapatocyte growth factor induction in human dermal fibroblasts by interleukin-1 and its prevention by interferon-gamma. Biochem Biophys Res Commun 2004;325:676-82.
31. Takami Y, Motoki T, Yamamoto I, Gohda E. Synergistic induction of hapatocyte growth factor in human skin fibroblasts by the inflammatory cytoldnes interleukin-1 and interferon-gamma. Biochem Biophys Res Commun 2005;327:212-7.
32. Inoue T, Hammaker D, Boyle DL, Firestein GS. Regulation of p38 MAPK kinases 3 and 6 in fibroblast-like synoviocytes. J Immunol 2005;174:4301-6.
33. Studer RK, Bergman R, Stubbs T, Decker K. Chondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibition. Arthritis Res Ther 2004;6:R56-64.